Home > Boards > US Listed > Medical - Drugs > Anika Therapeutics Inc. (ANIK)

Comtex SmarTrend(R)

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
EYEBUYSTOX Member Profile
 
Followed By 47
Posts 4,184
Boards Moderated 0
Alias Born 01/26/11
160x600 placeholder
Quarterly Report (10-q) Edgar (US Regulatory) - 5/22/2020 4:59:09 PM
Anika to Participate in 2020 UBS Virtual Global Healthcare Conference Business Wire - 5/12/2020 4:05:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/8/2020 6:02:08 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/7/2020 4:08:10 PM
Anika Reports First Quarter 2020 Financial Results GlobeNewswire Inc. - 5/7/2020 4:05:10 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/29/2020 4:17:07 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 4/29/2020 4:14:04 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/29/2020 4:07:06 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/28/2020 6:41:48 PM
Anika Names Cheryl R. Blanchard, Ph.D., as President and Chief Executive Officer Business Wire - 4/27/2020 8:30:00 AM
Anika to Issue First Quarter 2020 Financial Results and Business Highlights on Thursday, May 7 Business Wire - 4/23/2020 4:05:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/8/2020 4:06:04 PM
Anika Takes Actions to Strengthen Liquidity in Light of COVID-19 GlobeNewswire Inc. - 4/8/2020 4:05:10 PM
Unknown (sec Staff) Edgar (US Regulatory) - 3/18/2020 10:46:18 AM
Unknown (sec Staff) Edgar (US Regulatory) - 3/18/2020 10:45:38 AM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 3/13/2020 4:06:09 PM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 3/13/2020 4:06:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/6/2020 4:11:58 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 3/6/2020 4:06:48 PM
Annual Report (10-k) Edgar (US Regulatory) - 3/6/2020 6:02:04 AM
Anika Appoints David Colleran as General Counsel Business Wire - 3/4/2020 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/2/2020 4:06:17 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/27/2020 6:55:33 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/27/2020 6:54:46 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/27/2020 6:53:52 PM
EYEBUYSTOX   Tuesday, 03/29/11 11:15:18 AM
Re: None
Post # of 111 
Comtex SmarTrend(R)

Below are the top five most-efficient companies in the Health Care Supplies industry as ranked by Revenue Per Employee (RPE). Analysts use RPE as a measure to compare the productivity of companies in the same industry.

Alcon (NYSE:ACL) ranks first with an RPE of $0.46M; Immucor (NASDAQ:BLUD) ranks second with an RPE of $0.43M; and Anika Therapeutics (NASDAQ:ANIK) ranks third with an RPE of $0.42M.

Medical Action Industries (NASDAQ:MDCI) follows with an RPE of $0.4M and Quidel (NASDAQ:QDEL) rounds out the top five with an RPE of $0.34M.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist